Biosensing shows promise in detecting cancer, renal disease, and other illnesses. Depending on their transducing processes, varieties of biosensors can be divided into electrochemical, optical, piezoelectric, and thermal biosensors. Advancements in material production techniques, enzyme/protein designing, and immobilization/conjugation approaches can yield novel nanoparticles with further developed functionality. Research in cutting-edge biosensing with multifunctional nanomaterials, and the advancement of practical biochip plans utilizing nano-based sensing material, are of current interest. The miniaturization of electronic devices has enabled the growth of ultracompact, compassionate, rapid, and low-cost sensing technologies. Some sensors can recognize analytes at the molecule, particle, and single biological cell levels. Nanomaterial-based sensors, which can be used for biosensing quickly and precisely, can replace toxic materials in real-time diagnostics. Many metal-based NPs and nanocomposites are favorable for biosensing. Through direct and indirect labeling, metal-oxide NPs are extensively employed in detecting metabolic disorders, such as cancer, diabetes, and kidney-disease biomarkers based on electrochemical, optical, and magnetic readouts. The present review focused on recent developments across multiple biosensing modalities using metal/metal-oxide-based NPs; in particular, we highlighted the specific advancements of biosensing of key nanomaterials like ZnO, CeO2, and TiO2 and their applications in disease diagnostics and environmental monitoring. For example, ZnO-based biosensors recognize uric acid, glucose, cholesterol, dopamine, and DNA; TiO2 is utilized for SARS-CoV-19; and CeO2 for glucose detection.
Read full abstract